Quick Links

Employment Opportunities

McGill University is committed to diversity and equity in employment. It welcomes applications from indigenous peoples, visible minorities, ethnic minorities, persons with disabilities, women, persons of minority sexual orientations and gender identities and others who may contribute to further diversification.

Exam Invigilators

Invigilators are needed for the following mid-term exams:


An application form for all invigilator postings can be downloaded here.

Teaching Assistants

Teaching Assistants are needed for the following Fall 2014 courses:

Phar 300: Drug Action – 75 hours, 31 August 2014 – 03 January 2015 – 1 position available. Full details

Phar 503: Drug Design and Development – 30 hours, 31 August 2014 - 03 January 2015 – 2 positions available  Full details

Phar 562: General Pharmacology I – 30 hours, 31 August 2014 - 03 January 2015 – 2 positions available  Full details

Phar 599: Research Project in Pharmacology – 70 hours, 31 August 2014 - 03 January 2015 AND 04 January 2015 - 31 April 2015 – 1 position available  Full details

An application form for all teaching assistant postings can be downloaded here.

Postdoctoral Positions

Postdoctoral Fellow position in biochemical Pharmacology

Field: Research and Development

Location: McGill University, Montreal, Canada

Research Area: Biology and Life Science

Protein interactions in Alzheimer disease

Supervisor: Dr. Gerhard Multhaup
http://www.mcgill.ca/pharma/faculty-staff/faculty/gerhard-multhaup

Alzheimer disease (AD) is the most prevalent neurodegenerative disorder in the world, estimated to currently affect over 35 million people. Amyloid-β (Aβ) peptides are the primary culprits in the pathogenesis. Over the last several years, our research has focused on elucidating the molecular mechanisms of Aβ generation, particularly the interplay of APP and its processing secretases and we have made several key contributions (see refs below). We recently set up a new laboratory with state-of-the-art equipment and technology in the Department of Pharmacology & Therapeutics at McGill University in Montreal focused on research in the field of AD. The current objective of our research is to study in detail whether and how secretase modulators that have been shown to reduce the risk of developing AD have the ability to effectively and specifically interfere with the homointeractions of substrates and enzymes involved in Aβ generation, aggregation and Aβ-induced toxicity.

We offer:
The possibility to work on a cutting-edge project using state-of-the-art technology like Biacore and MALDI-MS in a highly motivated research team.
A stimulating international research environment and advanced training opportunities.
A competitive stipend.  The position is limited to 3 years.

Required:
PhD or equivalent in Molecular Biology, Biochemistry or related subjects
Motivation to work on complex biological problems

References:
Richter et al., Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14597-602
Botev et al., Biochemistry. 2011 Feb 8;50(5):828-35.
Kaden et al., EMBO Mol Med. 2012 Jul;4(7):647-59.
Olsson et al., J Biol Chem. 2013 Nov 13. [Epub ahead of print]

How to apply:
Please submit your application including CV, recommendation letter and certificates in one PDF to Chairsec Pharmacology chairsec [dot] pharmacology [at] mcgill [dot] ca

Graduate Student Positions

Graduate student in biochemical Pharmacology

Field: Research and Development

Location: McGill University, Montreal, Canada

Research Area: Biology and Life Science

Protein interactions in Alzheimer disease

Supervisor: Dr. Gerhard Multhaup
http://www.mcgill.ca/pharma/faculty-staff/faculty/gerhard-multhaup

Alzheimer disease (AD) is the most prevalent neurodegenerative disorder in the world, estimated to currently affect over 35 million people. Amyloid-β (Aβ) peptides are the primary culprits in the pathogenesis. Over the last several years, our research has focused on elucidating the molecular mechanisms of Aβ generation, particularly the interplay of APP and its processing secretases and we have made several key contributions (see refs below). We recently set up a new laboratory with state-of-the-art equipment and technology in the Department of Pharmacology & Therapeutics at McGill University in Montreal focused on research in the field of AD. The current objective of our research is to study in detail whether and how secretase modulators that have been shown to reduce the risk of developing AD have the ability to effectively and specifically interfere with the homointeractions of substrates and enzymes involved in Aβ generation, aggregation and Aβ-induced toxicity.

We offer:
The possibility to work on a cutting-edge project using state-of-the-art technology like Biacore and MALDI-MS in a highly motivated research team.
A stimulating international research environment and advanced training opportunities.
A competitive stipend.

Required for graduate studies:
Undergraduate degree or Master or Diploma in Molecular Biology, Biochemistry or related subjects.
Motivation to work on complex biological problems.

Find out more about our program and apply to graduate studies in Pharmacology at: http://www.mcgill.ca/pharma/prospective-students/graduate-program/applying-department. If accepted into our program for next september, you could start working in the lab prior to starting your graduate studies.

References:
Richter et al., Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14597-602
Botev et al., Biochemistry. 2011 Feb 8;50(5):828-35.
Kaden et al., EMBO Mol Med. 2012 Jul;4(7):647-59.
Olsson et al., J Biol Chem. 2013 Nov 13. [Epub ahead of print]

Research Assistants/Associates

Research Associate in the lab of Dr. Claudio Cuello - 1 position available.
Research area: ERK-CREB-CRE pathway, epigenetics and proteomics of Alzheimer's disease. Full details